SEC Form 4/A · accession 0001209191-15-014662
Auspex Pharmaceuticals, Inc. · ASPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Period of report
Feb 9, 2015
Accepted (ET)
Feb 17, 2015 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001454189
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 10, 2015 | S | 20,670 | $60.05 | D | 3,136,893 | D | |
| Common StockF1 | Feb 11, 2015 | S | 51,773 | $61.84 | D | 3,085,120 | D | |
| Common Stock | Feb 11, 2015 | S | 1,327 | $61.84 | D | 79,157 | I | By: CMEA Ventures VII (Parallel) LP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Amendment filed on 2/17/15 to correct Amount of Securities Beneficially Owned Following Reported Transaction.